已收盘 01-30 16:00:00 美东时间
-1.250
-1.27%
(来源:动脉新医药) 编者按:2026,制药巨头的命运拐点 一场前所未有的风暴正在全球制药行业的版图上积聚——2026年“专利悬崖”高峰。 仅在这一年...
01-30 11:59
今日重点评级关注:瑞穗:维持Syndax制药"跑赢大市"评级,目标价从410美元升至600美元;HC Wainwright & Co.:维持60 Degrees Pharmaceuticals, Inc."买入"评级,目标价从6美元升至24美元
01-28 10:59
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts jus...
01-28 00:40
Oppenheimer analyst Jay Olson maintains Revolution Medicines (NASDAQ:RVMD) with a Outperform and raises the price target from $75 to $150.
01-27 22:13
经历2024年生科寒冬之后,2025年全球并购强势回暖,交易规模再度突破千亿美元大关,直逼2023年水平。 医药魔方MedAlpha新药投融资数据库显示,20...
01-27 16:14
Revolution Medicines, Inc. ($RVMD) announced an update on their ongoing clinica...
01-27 00:31
Erasca stock fell Monday despite no company news, after reports said Merck ended acquisition talks with cancer drugmaker Revolution Medicines over valuation differences.
01-26 20:52
Merck (NYSE: MRK) reportedly ends discussions to acquire Revolution Medicines (NASDAQ: RVMD) after valuation disagreement.
01-26 19:01
大公司: 贾国龙:不再打造个人IP 西贝餐饮集团创始人贾国龙近日接受专访时表示,将回归一线、聚焦主业,不再打造个人IP。贾国龙表示,自己更愿意回归一线搞好服务...
01-26 18:15